share_log

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

Vertex Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

福泰製藥 | 144:擬議出售證券
美股SEC公告 ·  05/29 10:08

Moomoo AI 已提取核心訊息

Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
Vertex Pharmaceuticals Inc. officer Carmen Bozic is set to sell 2,280 shares of common stock on 05/29/2024, as announced by the company. The shares, valued at an aggregate market value of $1,015,876.80, were acquired by Bozic on 02/10/2024 through restricted stock vesting, a form of compensation from the issuer. This transaction follows a period where no securities were sold by Bozic in the past three months, as per the provided transaction history.
據Vertex Pharmicals Inc.宣佈,該公司高管卡門·博齊奇定於2024年5月29日出售2,280股普通股。這些股票的總市值爲1,015,876.80美元,由Bozic於2024年10月2日通過限制性股票歸屬收購,限制性股票歸屬是發行人的一種補償。根據提供的交易歷史記錄,這筆交易是在Bozic在過去三個月中沒有出售任何證券的時期之後進行的。
據Vertex Pharmicals Inc.宣佈,該公司高管卡門·博齊奇定於2024年5月29日出售2,280股普通股。這些股票的總市值爲1,015,876.80美元,由Bozic於2024年10月2日通過限制性股票歸屬收購,限制性股票歸屬是發行人的一種補償。根據提供的交易歷史記錄,這筆交易是在Bozic在過去三個月中沒有出售任何證券的時期之後進行的。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息